Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic from its shortage list, a move that will sharply curtail the compounders' ability to sell cheaper versions of the drugs.
Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of ...
Patients on semaglutide ( Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic ...
The Food and Drug Administration said Friday the shortage of Ozempic and Wegovy is over, a step that could spell the end to a booming market of cheap, pharmacy-made weight-loss drugs that has ...
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback